Results 11 to 20 of about 131,065 (253)

Distinct conformational states of SARS-CoV-2 spike protein [PDF]

open access: yesScience, 2020
A dynamic viral spike Efforts to protect human cells against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have focused on the trimeric spike (S) protein. Several structures have shown a stabilized ectodomain of the spike in its prefusion conformation. Cai et al.
Yongfei Cai, Jun Zhang, Tianshu Xiao
exaly   +4 more sources

Mutations and Evolution of the SARS-CoV-2 Spike Protein

open access: yesViruses, 2022
The SARS-CoV-2 spike protein mediates target recognition, cellular entry, and ultimately the viral infection that leads to various levels of COVID-19 severities. Positive evolutionary selection of mutations within the spike protein has led to the genesis
Nicholas Magazine   +5 more
doaj   +4 more sources

Amyloidogenesis of SARS-CoV-2 Spike Protein [PDF]

open access: yesJournal of the American Chemical Society, 2021
ABSTRACTSARS-CoV-2 infection is associated with a surprising number of morbidities. Uncanny similarities with amyloid-disease associated blood coagulation and fibrinolytic disturbances together with neurologic and cardiac problems led us to investigate the amyloidogenicity of the SARS-CoV-2 Spike protein (S-protein).
Sofie Nyström, Per Hammarström
openaire   +2 more sources

O-Glycosylation Landscapes of SARS-CoV-2 Spike Proteins [PDF]

open access: yesFrontiers in Chemistry, 2021
The densely glycosylated spike (S) proteins that are highly exposed on the surface of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) facilitate viral attachment, entry, and membrane fusion. We have previously reported all the 22  N -glycosites and site-specific
Yong Zhang   +10 more
openaire   +3 more sources

Expression and characterization of SARS-CoV-2 spike proteins [PDF]

open access: yesNature Protocols, 2021
The severe acute respiratory syndrome coronavirus 2 spike protein is a critical component of coronavirus disease 2019 vaccines and diagnostics and is also a therapeutic target. However, the spike protein is difficult to produce recombinantly because it is a large trimeric class I fusion membrane protein that is metastable and heavily glycosylated.
Jeffrey M. Schaub   +19 more
openaire   +2 more sources

Structure of SARS-CoV-2 spike protein

open access: yesCurrent Opinion in Virology, 2021
The COVID-19 (coronavirus disease 2019) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to loss of human life in millions and devastating socio-economic consequences worldwide. The disease has created urgent needs for intervention strategies to control the crisis and meeting these needs requires a deep ...
Jun Zhang   +3 more
openaire   +2 more sources

SARS-CoV-2 Spike Protein Interaction Space

open access: yesInternational Journal of Molecular Sciences, 2023
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a +sense single-strand RNA virus. The virus has four major surface proteins: spike (S), envelope (E), membrane (M), and nucleocapsid (N), respectively. The constitutive proteins present a high grade of symmetry. Identifying a binding site is difficult. The virion is approximately 50–200 nm
Claudiu N. Lungu, Mihai V. Putz
openaire   +2 more sources

A thermostable, closed, SARS-CoV-2 spike protein trimer [PDF]

open access: yesNature Structural & Molecular Biology, 2020
AbstractThe spike (S) protein of SARS-CoV-2 mediates receptor binding and cell entry and is the dominant target of the immune system. S exhibits substantial conformational flexibility. It transitions from closed to open conformations to expose its receptor binding site, and subsequently from prefusion to postfusion conformations to mediate fusion of ...
Xiaoli Xiong   +86 more
openaire   +4 more sources

SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis

open access: yesMicrobiology Spectrum, 2021
SARS-CoV-2 causes complex effects on microvascular homeostasis that potentially contribute to organ dysfunction and coagulopathies. SARS-CoV-2 binds to, and causes downregulation of angiotensin converting enzyme 2 (ACE2) on cells that it infects.
Soumya Panigrahi   +8 more
openaire   +3 more sources

Neutralizing antibodies targeting SARS-CoV-2 spike protein

open access: yesStem Cell Research, 2021
SARS-CoV-2 causing the worldwide pandemic has changed people's life in multiple aspects dramatically since it's first identified in Wuhan, China at the end of 2019. While the numbers of infected patients and death toll keep vigorous increasing, curbing the progression of the pandemic is an urgent goal.
Xiaojie, Shi   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy